WellDoc Communications

Welldoc is a digital health leader specializing in the development of digital therapeutics for chronic disease management. The company's flagship product, BlueStar, is an FDA-cleared digital therapeutic for adults with type 1 and type 2 diabetes, offering personalized, real-time coaching and clinical insights. Beyond diabetes, Welldoc provides a comprehensive chronic care platform that addresses hypertension, heart failure, and behavioral health. The company collaborates extensively with life science leaders and health plans to integrate its software-as-a-medical-device (SaMD) solutions into the standard of care, aiming to improve clinical outcomes and patient engagement at scale.